Anuva is creating the world’s most diverse Genomic Bio/Data Bank to help uncover novel biological pathways for drug discovery. Anuva is a translational research company that is creating the most diverse Genomic Bio/Data Bank of Asian Populations, which is being utilized for research & development within the pharma industry. Our cohorts and biorepository allow for follow-on clinical and translational studies, which greatly empower drug development opportunities.
| Website | https://anuva.bio/ |
| Revenue | $5.8 million |
| Employees | 55 (26 on RocketReach) |
| Founded | 2013 |
| Industry | Research Services |
| Keywords | Drug Discovery, Genomics, Biological Pathways, Translational Research, Precision Medicine, Data Analytics, Molecular Diagnostics, Pharmaceutical Research, Biotechnology, Health Informatics, Genome Sequencing, Genetic Data, Big Data, Clinical Research, Bioinformatics, Novel Therapeutics, Personalized Medicine |
| Competitors | Amgen, BASF, Novozymes, Zymergen, Inc., Amyris, Solugen, Codexis, Inc., Arzeda, Synthace, Geno +43 more (view full list) |
Looking for a particular Anuva employee's phone or email?
The Anuva annual revenue was $5.8 million in 2026.
Jonathan Picker is the Co-Founder and CEO of Anuva.
26 people are employed at Anuva.